Our results show that both p-LRRK2S935 and VPS35 protein levels were or tended to increase in PDD samples compared to DLB (Fig. 4), which is consistent with previous findings that PD-linked VPS35 mutations can induce dopaminergic neurodegeneration [65]. The gene discussed is VPS35; the disease is Parkinson disease.